CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumorsJiawan Wang(Johns Hopkins University), Christine A. Pratilas(Johns Hopkins University)bioRxiv (Cold Spring Harbor Laboratory)February 3, 202310.1101/2023.02.02.526674Cited by 5SaveCiteExport RISWatch citationsRelated PapersTargeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma|Oncogene|2022|41CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors|Science Advances|2023|26